novo nordisk glp-1 receptor agonist medications GLP-1 diabetes drugs like Ozempic may modestly reduce cancer risks List of GLP-1 Receptor Agonists

Additionally, the loss of muscle mass has been problematic for some individuals taking this class of medication, with lean body mass accounting for up to 1540% of total weight loss

Neuropsychiatric safety with liraglutide 3.0 mg for weight management: results from randomized controlled phase 2 and 3a trials

Both cause similar side effects, primarily gastrointestinal issues like nausea, diarrhea, and constipation

When Saxenda still makes sense to discuss You tried semaglutide or tirzepatide and experienced side effects that limited tolerance Your clinician has a specific clinical reason to prefer liraglutide in your case You are a younger adolescent where Saxenda has a longer-standing approval history than semaglutide Availability or cost considerations make liraglutide more accessible for your situation A few things to keep in mind before comparing these medications Clinical trial averages describe populations, not individuals

Common Questions about GLP-1s vs